CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Other events
- UPLOAD Other SEC-generated Letter
- 8-K Event Results of operations · Shareholder vote results · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 29 · 564 filings